guiding biotech to the top
from start-up to exit
Our approach
we specialise in supporting and advising biotech and life sciences companies through every stage of their life cycle, from inception, through product development to a successful exit. Our bespoke advisory services are designed to support fast growth, innovation driven biotech companies in areas such as strategic and competitive positioning, technology and product development, go-to-market strategy, M&A and corporate development. Our objective is to provide enabling advise that leads to achieving your business goals.
Our services
About Us
At i2i capital, we bring together decades of leadership, scientific innovation, and strategic expertise to help life sciences and biotechnology companies thrive in a complex, fast-evolving landscape. Founded and led by seasoned executives Heikki Lanckriet, Amy Walker, and David Roth our expertise stands at the intersection of deep industry knowledge and hands-on operational experience.
Bio-chemical engineer with over 25 years commercial & scientific experience in life sciences and a track record of developing high growth technology businesses
Heikki Lanckriet, PhD
Molecular biologist with a passion for bringing innovative products and technologies to market. Strong expertise in technical and operational and commercial aspects of life science businesses
Amy Walker, PhD
Chartered accountant with a background in professional services, PE and listed companies. Enjoys working with growth companies and has deep experience in corporate transactions
David Roth, CA